NCT01733394View on ClinicalTrials.gov

Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 12, 2012

Primary Completion Date

September 26, 2016

Study Completion Date

September 26, 2016

Conditions
Epilepsy
Interventions
DRUG

"Lamotrigine Generic A Lamotrigine Generic B Lamotrigine Brand"

DRUG

lamotrigine

Trial Locations (8)

35294

University of Alabama at Birmingham, Birmingham

52242

University of Iowa, Iowa City

53705

University of Wisconsin-Madison, Madison

66160

University of Kansas, Kansas City

50311-4505

Drake University, Des Moines

02115

Brigham and Women's Hospital, Boston

14642-8673

University of Rochester Medical Center, Rochester

45267-0525

University of Cincinnati Medical Center, Cincinnati

All Listed Sponsors
collaborator

American Epilepsy Society

OTHER

collaborator

Epilepsy Foundation

OTHER

lead

University of Cincinnati

OTHER

NCT01733394 - Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study) | Biotech Hunter | Biotech Hunter